# Recursion Pharmaceuticals

运营最大规模的机器人表型筛选设施之一以生成lab-in-the-loop数据（Recursion OS）；2024年11月与Exscientia合并，组成端到端AI发现公司。

Source: https://cn.bioecon.ru/companies/recursion-pharmaceuticals/
Updated: 2026-06-30

- 国家: United States

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 产能 | 每周最多200万次实验 | https://www.recursion.com/, https://www.recursion.com/platform, https://www.sec.gov/Archives/edgar/data/1601830/000160183026000097/rxrx_augustcorporatepres.htm |
| 生产基地 | 位于犹他州盐湖城及牛津郡Milton Park的自动化实验室 | https://ir.recursion.com/news-releases/news-release-details/recursion-reports-first-quarter-financial-results-and-provides, https://www.recursion.com/platform, https://www.sec.gov/Archives/edgar/data/1601830/000160183026000038/exhibit991-10xk25.htm, https://www.sec.gov/Archives/edgar/data/1601830/000160183026000097/exhibit991-q0226.htm, https://www.sec.gov/Archives/edgar/data/1601830/000160183026000097/rxrx_augustcorporatepres.htm |
| 员工人数 | 550名员工 | https://ir.recursion.com/news-releases/news-release-details/recursion-and-exscientia-two-leaders-ai-drug-discovery-space |
| 营收 | 2026年第一季度为$650万 | https://www.sec.gov/Archives/edgar/data/1601830/000160183026000038/exhibit991-10xk25.htm, https://www.sec.gov/Archives/edgar/data/1601830/000160183026000077/exhibit991-q0126.htm |
| 监管批准 | 公司须遵守全面的监管要求才能将候选药物商业化 [中等置信度] | https://ir.recursion.com/news-releases/news-release-details/recursion-reports-first-quarter-financial-results-and-provides, https://ir.recursion.com/static-files/2c14950d-fa75-4012-9320-7f51c826b84b, https://www.sec.gov/Archives/edgar/data/1601830/000160183026000038/exhibit991-10xk25.htm, https://www.sec.gov/Archives/edgar/data/1601830/000160183026000077/exhibit991-q0126.htm |

独立来源: ir.recursion.com, sec.gov

## 技术

- [AI药物设计与AlphaFold应用](https://cn.bioecon.ru/technology/ai-drug-design-alphafold-applications/)